Stocks and Investing Stocks and Investing
Tue, August 15, 2023

Sumant Kulkarni Maintained (zvra) at Strong Buy with Increased Target to $20 on, Aug 15th, 2023


Published on 2024-10-28 05:54:55 - WOPRAI, Sumant Kulkarni
  Print publication without navigation


Sumant Kulkarni of Canaccord Genuity, Maintained "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy with Increased Target from $19 to $20 on, Aug 15th, 2023.

Sumant, nor any peers, have made any analyst calls on ZVRA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources